Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imaging of adrenocortical metastases with [11C]metomidate.

× No keyword cloud information.

3 in total

1. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.

Authors: M Bergström; C Juhlin; T A Bonasera; A Sundin; J Rastad; G Akerström; B Långström
Journal: J Nucl Med Date: 2000-02 Impact factor: 10.057

2. FDG-PET in adrenocortical carcinoma.

Authors: A Becherer; H Vierhapper; C Pötzi; G Karanikas; A Kurtaran; J Schmaljohann; A Staudenherz; R Dudczak; K Kletter
Journal: Cancer Biother Radiopharm Date: 2001-08 Impact factor: 3.099

3. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.

Authors: Georg Zettinig; Markus Mitterhauser; Wolfgang Wadsak; Alexander Becherer; Christian Pirich; Heinrich Vierhapper; Bruno Niederle; Robert Dudczak; Kurt Kletter
Journal: Eur J Nucl Med Mol Imaging Date: 2004-06-10 Impact factor: 9.236

3 in total

Review 1. Molecular imaging of adrenal neoplasms.

Authors: Clara C Chen; Jorge A Carrasquillo
Journal: J Surg Oncol Date: 2012-05-24 Impact factor: 2.885

2. Para-chloro-2-[¹⁸F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging.

Authors: Isabella Silins; Anders Sundin; Patrik Nordeman; Mahabuba Jahan; Sergio Estrada; Azita Monazzam; Mark Lubberink; Franklin Aigbirhio; Per Hellman; Gunnar Antoni
Journal: Int J Med Sci Date: 2021-03-21 Impact factor: 3.738

3. Novel CYP11B-ligand [^123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience.

Authors: Britta Heinze; Andreas Schirbel; Lukas Nannen; David Michelmann; Philipp E Hartrampf; Christina Bluemel; Magdalena Schneider; Ken Herrmann; Heribert Haenscheid; Martin Fassnacht; Andreas K Buck; Stefanie Hahner
Journal: Eur J Nucl Med Mol Imaging Date: 2021-07-03 Impact factor: 9.236

3 in total

Imaging of adrenocortical metastases with [11C]metomidate.

1. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.

2. FDG-PET in adrenocortical carcinoma.

3. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.

Review 1. Molecular imaging of adrenal neoplasms.

2. Para-chloro-2-[18F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging.

3. Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience.

2. Para-chloro-2-[¹⁸F]fluoroethyl-etomidate: A promising new PET radiotracer for adrenocortical imaging.

3. Novel CYP11B-ligand [^123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience.